The historical rank and industry rank for Sopharma AD-Sofia's FCF Margin % or its related term are showing as below:
WAR:SPH'
s FCF Margin % Range Over the Past 10 Years
Min: -14.32 Med: -7.19 Max: 5.2
Current: -2.45
During the past 13 years, the highest FCF Margin % of Sopharma AD-Sofia was 5.20%. The lowest was -14.32%. And the median was -7.19%.
WAR:SPH's FCF Margin % is ranked worse than 76.27% of 118
companies
in the Medical Distribution industry
Industry Median: 1.06
vs WAR:SPH: -2.45
Sopharma AD-Sofia FCF Margin % Related Terms
Sopharma AD-Sofia FCF Margin % Historical Data
* Premium members only.
The historical data trend for Sopharma AD-Sofia's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Sopharma AD-Sofia's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma AD-Sofia FCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Sopharma AD-Sofia's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sopharma AD-Sofia (WAR:SPH) has a FCF Margin % of 2.41% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sopharma AD-Sofia and its competitors. According to the industry distribution chart, Sopharma AD-Sofia ranks #90 out of 118 companies in the Medical Distribution industry, placing it in the top 76.3%.
Is Sopharma AD-Sofia's FCF Margin % too high?
Sopharma AD-Sofia's current FCF Margin % is 2.41%. The Medical Distribution industry median FCF Margin % is 1.06. Sopharma AD-Sofia's value of 2.41% is 127.4% above this industry median. Based on the distribution chart, Sopharma AD-Sofia ranks #90 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Sopharma AD-Sofia has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sopharma AD-Sofia's FCF Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sopharma AD-Sofia ranks #90 out of 118 companies for FCF Margin %. This places Sopharma AD-Sofia in the lower half of its industry. The industry median FCF Margin % is 1.06. Sopharma AD-Sofia's value of 2.41% is 127.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 1.06, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sopharma AD-Sofia's current FCF Margin % of 2.41% is 127.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sopharma AD-Sofia and its competitors. For the Medical Distribution industry, the median FCF Margin % is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sopharma AD-Sofia's current FCF Margin % is 2.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma AD-Sofia stock overvalued right now?
Based on GuruFocus' analysis, Sopharma AD-Sofia (WAR:SPH) is currently considered Possible Value Trap. The stock's GF Value™ is zł13.56, compared to a current price of zł7.92 — trading 41.6% below its estimated fair value. The current FCF Margin % is 2.41% and 127.4% above the Medical Distribution industry median of 1.06. Sopharma AD-Sofia's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Sopharma AD-Sofia (WAR:SPH), the current FCF Margin % is 2.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sopharma AD-Sofia (WAR:SPH) Overvalued in 2026?
Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued.
The current stock price of zł7.92 is trading 41.6% below its estimated GF Value™ of zł13.56.
GuruFocus considers Sopharma AD-Sofia to be Possible Value Trap.
Key valuation signals for WAR:SPH:
FCF Margin %: 2.41%
GF Value™: zł13.56 vs. price of zł7.92 (41.6% below fair value)
Industry Position: 127.4% above the Medical Distribution median (#90 of 118)
No single metric tells the full story. See the WAR:SPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
67GF Score
Get the complete analysis for WAR:SPH
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:SPH has been successfully added to your 
